EyeCon 2026 Banner
|Articles|June 9, 2004

FDA approves ISTA product, asked to evaluate another

On May 6 the FDA approved ISTA Pharmaceutical's new drug application (NDA) for lyophilized, ovine hyaluronidase for injection (Vitrase) for use as a spreading agent to facilitate the dispersion and absorption of other drugs.

Latest CME